Increased numbers of NK cells, NKT-like cells, and NK inhibitory receptors in peripheral blood of patients with chronic obstructive pulmonary disease

Clinical and Developmental Immunology

Volumn 2013, Issue , 2013, Pages

  Tang, Ying ^a   Li, Xiaodan ^a   Wang, Man ^a   Zou, Qi ^a   Zhao, Shasha ^a   Sun, Bowen ^a   Xu, Lijun ^a   Jiang, Yanfang ^a  

^a JILIN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD56 ANTIGEN; GAMMA INTERFERON; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL1; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL2; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL3; NATURAL KILLER CELL RECEPTOR;

ADULT; ARTICLE; B LYMPHOCYTE; BLOOD; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FLOW CYTOMETRY; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; LUNG FUNCTION; LYMPHOCYTE SUBPOPULATION; MALE; NATURAL KILLER CELL; NATURAL KILLER T CELL; PATHOGENESIS; PREDICTION; PRIORITY JOURNAL; T LYMPHOCYTE; CASE CONTROL STUDY; IMMUNOLOGY; IMMUNOPHENOTYPING; LUNG FUNCTION TEST; LYMPHOCYTE COUNT; METABOLISM; MIDDLE AGED;

CASE-CONTROL STUDIES; FEMALE; HUMANS; IMMUNOPHENOTYPING; KILLER CELLS, NATURAL; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; NATURAL KILLER T-CELLS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RECEPTORS, KIR2DL1; RECEPTORS, KIR2DL3; RECEPTORS, NATURAL KILLER CELL; RESPIRATORY FUNCTION TESTS;

EID: 84884257335     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2013/721782     Document Type: Article

References (37)

1. Lopez A. D., Mathers C. D., Ezzati M., Jamison D. T., Murray C. J., Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. The Lancet 2006 367 9524 1747 1757 2-s2.0-33646799069 10.1016/S0140-6736(06)68770-9
2. Rabe K. F., Hurd S., Anzueto A., Barnes P. J., Buist S. A., Calverley P., Fukuchi Y., Jenkins C., Rodriguez-Roisin R., Van Weel C., Zielinski J., Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. The American Journal of Respiratory and Critical Care Medicine 2007 176 6 532 555 2-s2.0-34548660457 10.1164/rccm.200703-456SO
3. Miller L. G., Goldstein G., Murphy M., Ginns L. C., Reversible alterations in immunoregulatory T cells in smoking. Analysis by monoclonal antibodies and flow cytometry. Chest 1982 82 5 526 529 2-s2.0-0020386025
4. Ginns L. C., Goldenheim P. D., Miller L. G., Burton R. C., Gillick L., Colvin R. B., Goldstein G., Kung P. C., Hurwitz C., Kazemi H., T-lymphocyte subsets in smoking and lung cancer. Analysis by monoclonal antibodies and flow cytometry. The American Review of Respiratory Disease 1982 126 2 265 269 2-s2.0-0019959509
5. Gupta J., Chattopadhaya D., Bhadoria D. P., Pasha M. A. Q., Gupta V. K., Kumar M., Dabur R., Yadav V., Sharma G. L., T lymphocyte subset profile and serum alpha-1-antitrypsin in pathogenesis of chronic obstructive pulmonary disease. Clinical and Experimental Immunology 2007 149 3 463 469 2-s2.0-34547901395 10.1111/j.1365-2249.2007.03429.x
6. Di Stefano A., Turato G., Maestrelli P., Mapp C. E., Ruggieri M. P., Roggeri A., Boschetto P., Fabbri L. M., Saetta M., Airflow limitation in chronic bronchitis is associated with T-lymphocyte and macrophage infiltration of the bronchial mucosa. The American Journal of Respiratory and Critical Care Medicine 1996 153 2 629 632 2-s2.0-0030061718
7. + T lymphocytes with FEV1. The American Journal of Respiratory and Critical Care Medicine 1997 155 3 852 857 2-s2.0-0030900606
8. Bosken C. H., Hards J., Gatter K., Hogg J. C., Characterization of the inflammatory reaction in the peripheral airways of cigarette smokers using immunocytochemistry. The American Review of Respiratory Disease 1992 145 4, part 1 911 917 2-s2.0-0026591525
9. Colucci F., Caligiuri M. A., Di Santo J. P., What does it take to make a natural killer? Nature Reviews Immunology 2003 3 5 413 425 2-s2.0-0037711333 10.1038/nri1088
10. Johansson S., Berg L., Hall H., Höglund P., NK cells: elusive players in autoimmunity. Trends in Immunology 2005 26 11 613 618 2-s2.0-28444474862 10.1016/j.it.2005.08.008
11. Baxter A. G., Smyth M. J., The role of NK cells in autoimmune disease. Autoimmunity 2002 35 1 1 14 2-s2.0-0036082290 10.1080/08916930290005864
12. Andoniou C. E., van Dommelen S. L. H., Voigt V., Andrews D. M., Brizard G., Asselin-Paturel C., Delale T., Stacey K. J., Trinchieri G., Degli-Esposti M. A., Interaction between conventional dendritic cells and natural killer cells is integral to the activation of effective antiviral immunity. Nature Immunology 2005 6 10 1011 1019 2-s2.0-27144554984 10.1038/ni1244
13. Mallevaey T., Clarke A. J., Scott-Browne J. P., Young M. H., Roisman L. C., Pellicci D. G., Patel O., Vivian J. P., Matsuda J. L., McCluskey J., Godfrey D. I., Marrack P., Rossjohn J., Gapin L., A molecular basis for NKT cell recognition of CD1d-self-antigen. Immunity 2011 34 3 315 326 2-s2.0-79952752495 10.1016/j.immuni.2011.01.013
14. Prieto A., Reyes E., Bernstein E. D., Martinez B., Monserrat J., Izquierdo J. L., Callol L., De Lucas P., Alvarez-Sala R., Alvarez-Sala J. L., Villarrubia V. G., Alvarez-Mon M., Defective natural killer and phagocytic activities in chronic obstructive pulmonary disease are restored by glycophosphopeptical (Inmunoferón). The American Journal of Respiratory and Critical Care Medicine 2001 163 7 1578 1583 2-s2.0-0034948629
15. Urbanowicz R. A., Lamb J. R., Todd I., Corne J. M., Fairclough L. C., Altered effector function of peripheral cytotoxic cells in COPD. Respiratory Research 2009 10 article 53 2-s2.0-70249142044 10.1186/1465-9921-10-53
16. Vivier E., Raulet D. H., Moretta A., Caligiuri M. A., Zitvogel L., Lanier L. L., Yokoyama W. M., Ugolini S., Innate or adaptive immunity? The example of natural killer cells. Science 2011 331 6013 44 49 2-s2.0-78650970845 10.1126/science.1198687
17. Watzl C., Long E. O., Signal transduction during activation and inhibition of natural killer cells. Current Protocols in Immunology 2010 11 11.9B 2-s2.0-77956481004 10.1002/0471142735.im1109bs35
18. Biron C. A., Brossay L., NK cells and NKT cells in innate defense against viral infections. Current Opinion in Immunology 2001 13 4 458 464 2-s2.0-0035424543 10.1016/S0952-7915(00)00241-7
19. Stewart C. A., Vivier E., Colonna M., Strategies of natural killer cell recognition and signaling. Current Topics in Microbiology and Immunology 2005 298 1 21 2-s2.0-27144495433
20. López-Botet M., Llano M., Navarro F., Bellon T., NK cell recognition of non-classical HLA class I molecules. Seminars in Immunology 2000 12 2 109 119 2-s2.0-0242652204 10.1006/smim.2000.0213
21. Ljunggren H. G., Karre K., In search of the "missing self": MHC molecules and NK cell recognition. Immunology Today 1990 11 7 237 244 2-s2.0-0025300414
22. Vilches C., Parham P., KIR: diverse, rapidly evolving receptors of innate and adaptive immunity. Annual Review of Immunology 2002 20 217 251 2-s2.0-0036215134 10.1146/annurev.immunol.20.092501.134942
23. Janeway C. A. Jr., Medzhitov R., Innate immune recognition. Annual Review of Immunology 2002 20 197 216 2-s2.0-0036212849 10.1146/annurev.immunol.20. 083001.084359
24. Miller M. R., Hankinson J., Brusasco V., Burgos F., Casaburi R., Coates A., Crapo R., Enright P., van der Grinten C. P. M., Gustafsson P., Jensen R., Johnson D. C., MacIntrye N., McKay R., Navajas D., Pedersen O. F., Pellegrino R., Viegi G., Wagner J., Standardisation of spirometry. European Respiratory Journal 2005 26 2 319 338 2-s2.0-21744460289 10.1183/09031936.05.00034805
25. Monaco C., Andreakos E., Kiriakidis S., Feldmann M., Paleolog E., T-cell-mediated signalling in immune, inflammatory and angiogenic processes: the cascade of events leading to inflammatory diseases. Current Drug Targets: Inflammation and Allergy 2004 3 1 35 42 2-s2.0-2942602599 10.2174/ 1568010043483881
26. Herrmann M., Voll R. E., Kalden J. R., Etiopathogenesis of systemic lupus erythematosus. Immunology Today 2000 21 9 424 426 2-s2.0-0033823583 10.1016/S0167-5699(00)01675-3
27. Jeffery P. K., Structural and inflammatory changes in COPD: a comparison with asthma. Thorax 1998 53 2 129 136 2-s2.0-0031954369
28. Cosio M. G., Guerassimov A., Chronic obstructive pulmonary disease: inflammation of small airways and lung parenchyma. The American Journal of Respiratory and Critical Care Medicine 1999 160 5, part 2 S21 S25 2-s2.0-0032719586
29. Biron C. A., Initial and innate responses to viral infections-pattern setting in immunity or disease. Current Opinion in Microbiology 1999 2 4 374 381 2-s2.0-0033178448 10.1016/S1369-5274(99)80066-6
30. Orange J. S., Formation and function of the lytic NK-cell immunological synapse. Nature Reviews Immunology 2008 8 9 713 725 2-s2.0-50249184550 10.1038/nri2381
31. Bordignon C., Villa F., Vecchi A., Giavazzi R., Introna M., Avallone R., Mantovani A., Natural cytotoxic activity in human lungs. Clinical and Experimental Immunology 1982 47 2 437 444 2-s2.0-0020072955
32. Robinson B. W. S., Pinkston P., Crystal R. G., Natural killer cells are present in the normal human lung but are functionally impotent. Journal of Clinical Investigation 1984 74 3 942 950 2-s2.0-0021219282
33. Culley F. J., Natural killer cells in infection and inflammation of the lung. Immunology 2009 128 2 151 163 2-s2.0-69949117722 10.1111/j.1365-2567.2009. 03167.x
34. Tanaka J., Tutumi Y., Mori A., Ohta S., Kobayashi S., Asaka M., Imamura M., Sequential analysis of HLA-C-specific killer cell inhibitory receptor (CD158b) expressing peripheral blood mononuclear cells during chronic graft-versus-host disease. Bone Marrow Transplantation 2000 26 3 287 290 2-s2.0-0033860891
35. Velardi A., Role of KIRs and KIR ligands in hematopoietic transplantation. Current Opinion in Immunology 2008 20 5 581 587 2-s2.0-50549099901 10.1016/j.coi.2008.07.004
36. Guerra N., Guillard M., Angevin E., Echchakir H., Escudier B., Moretta A., Chouaib S., Caignard A., Killer inhibitory receptor (CD158b) modulates the lytic activity of tumor-specific T lymphocytes infiltrating renal cell carcinomas. Blood 2000 95 9 2883 2889 2-s2.0-0034194378
37. Zhu X., Gadgil A. S., Givelber R., George M. P., Stoner M. W., Sciurba F. C., Duncan S. R., Peripheral T cell functions correlate with the severity of chronic obstructive pulmonary disease. Journal of Immunology 2009 182 5 3270 3277 2-s2.0-64849091023 10.4049/jimmunol.0802622